Observation of the curative effect of phakic intraocular lens implantation in correction of moderate and low refractive errors-randomized controlled clinical trial (RCT)

Clinical observation of phakic intraocular lens implantation (ICL) in correction of low to moderate myopia: a randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055372

Enrollment

Unknown

Registered

2022-01-08

Start date

2018-01-01

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

ICL group:Intraocular lens implantation

SMILE group:SMILE surgey

Eligibility

Sex/Gender

All

Age

21 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 21 years; 2. Preoperative refractive status has been stable for more than 2 years; 3. Preoperative equivalent spherical mirror<=6.0D; 4. There is no history of active eye inflammation and other eye diseases in routine preoperative examination; 5. The cornea is transparent without pannus or pannus, and the shape is normal; 6. Have indications for ICL or TICL surgery; 7. Voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Associated with systemic connective tissue diseases and autoimmune diseases; 2. Combined with systemic diseases such as hypertension, heart disease and diabetes; 3. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
uncorrected distance vision;cornel endothelium;intraocular pressure;vault;	—

Secondary

Measure	Time frame
equivalent spherical mirror;4mm cornea, whole eye higher order aberrations;	—

Countries

China

Contacts

Public ContactLi Kangjun

Xi'an Aier Eye Hospital

kj4907630@foxmail.com+86 13002938520

Outcome results